Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

B of A Securities Downgrades Lear to Underperform

B of A Securities analyst John Murphy downgrades Lear (NYSE:LEA) from Neutral to Underperform.

byBenzinga Newsdesk

September 16, 2021

1 minute read

B of A Securities analyst John Murphy downgrades Lear (NYSE:LEA) from Neutral to Underperform.

Hain Celestial Q1 Earnings Top Estimates, Reaffirms FY22 Outlook

By Shivani Kumaresan

Today, 2:19 PM

Hain Celestial Group Inc (NASDAQ:HAIN) reported a first-quarter FY22 sales decline of 8.8% year-on-year, to $454.9 million, beating the analyst consensus…

HAIN

Needham Maintains Buy on EPAM Sys, Raises Price Target to $415

By Benzinga Newsdesk

Today, 2:19 PM

Needham analyst Mayank Tandon maintains EPAM Sys (NYSE:EPAM) with a Buy and raises the price target from $400 to $415.

EPAM

Acorda Therapeutics Q2 EPS $(3.15) Down From $(1.87) YoY, Sales $31.05M Miss $36.97M Estimate

By Benzinga Newsdesk

Today, 2:19 PM

Acorda Therapeutics (NASDAQ:ACOR) reported quarterly losses of $(3.15) per share. This is a 68.45 percent decrease over losses of $(1.87) per share from the same period last year. The company reported quarterly sales of

ACOR